Delivery Order SPE2DB22D2206-SPE2DB23FJV63
Award Date 8/17/23
Potential Completion Date 8/18/23
Potential Value $2.4K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,221.00 to AmerisourceBergen Drug Corp for the supply of Temozolomide 100 mg capsules (14-count units) on November 13, 2025, with an ultimate completion date of November 14, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. Temozolomide is an oral chemotherapy medication used primarily in the...
- The Defense Logistics Agency awarded a $1,887.90 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 180 mg temozolomide capsules. The order is for five packages of the chemotherapy medication and will be fulfilled from Amerisourcebergen's facility located in Conshohocken, Pennsylvania by July 21, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for temozolomide capsules supports the DLA's mission to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Temozolomide 140 mg capsules (14-count units) with a ceiling value of $3,561.36. This is a firm fixed-price delivery order with an ultimate completion date of November 3, 2025, and represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, the pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Temozolomide 100 mg capsules (quantity 14) with a ceiling value of $3,358.08. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by October 21, 2025. The award represents a continuation of AmerisourceBergen's extensive role in federal...
- The Defense Logistics Agency awarded a $1,619.50 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 250 mg temozolomide capsules. Under this order, Amerisourcebergen will deliver 5 boxes of the chemotherapy drug to a facility in Conshohocken, Pennsylvania by September 19, 2023. As the Defense Logistics Agency is responsible for procuring medical supplies and pharmaceuticals for the U.S. military and other government agencies, this order is likely intended...
- The Defense Logistics Agency awarded a $2,253.38 firm fixed price delivery order to Amerisourcebergen Drug Corporation for temozolomide 140 mg capsules. Under this order, Amerisourcebergen will deliver 5 units of the specified chemotherapy drug to a facility located in Conshohocken, Pennsylvania by June 26, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations, suggesting this procurement supports medical supplies for DOD facilities and personnel....
- The Defense Logistics Agency awarded a $100,600 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the provision of 5,000 Temozolomide 5 mg capsules to support the Department of Defense's medical supply needs. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products from its facility in Conshohocken, Pennsylvania by July 28, 2023 to fulfill requirements under the agency's pharmaceutical supply vehicle. No subcontractors or set aside...
- The Defense Logistics Agency awarded a $3,038.40 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 140 mg temozolomide capsules. The place of performance is Conshohocken, Pennsylvania and the period of performance runs through October 17, 2023. No set-aside provisions were applied to this award placed under an existing vehicle. The temozolomide capsules will support DLA's mission to provide pharmaceuticals and other medical supplies to the U.S. military...
- The Defense Logistics Agency awarded a $199,200 firm fixed price delivery order to Amerisourcebergen Drug Corporation for temozolomide 100 mg capsules. The delivery order was issued against an existing Prime Vendor contract vehicle to supply pharmaceutical products and services to DLA and DoD customers. Performance will take place in Conshohocken, Pennsylvania over a three day period concluding on July 3, 2023. No subcontractors or set aside designations were identified. The temozolomide...
- The Defense Logistics Agency awarded a $1,101.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Temozolomide 100 mg capsules (14-count) on January 6, 2026, with completion scheduled for January 7, 2026. This non-set-aside award is being performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal healthcare systems including military treatment...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB23FJV63Delivery Order
The Defense Logistics Agency awarded a $2,375.97 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the provision of 14 capsules of Temozolomide 180 mg. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is August 17, 2023 through August 18, 2023. Temozolomide is a chemotherapy drug used to treat certain types of brain tumors. This delivery order was awarded under an existing DLA pharmaceutical supply vehicle and does not have any special set-aside designations. Amerisourcebergen will fulfill the order using its normal distribution processes to supply this chemotherapy medication in support of DLA and broader DoD health programs.
Generated 12/17/23, 6:51 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 8/17/23 |